In vitro anticancer effects of alpelisib against PIK3CA‑mutated canine hemangiosarcoma cell lines.
Maeda M, Ochiai K, Michishita M, Morimatsu M, Sakai H, Kinoshita N, Sakaue M, Onozawa E, Azakami D, Yamamoto M, Ishioka K, Sadahira T, Watanabe M, Tanaka Y.
Maeda M, et al. Among authors: morimatsu m.
Oncol Rep. 2022 Apr;47(4):84. doi: 10.3892/or.2022.8295. Epub 2022 Mar 2.
Oncol Rep. 2022.
PMID: 35234262
Free PMC article.